Neuromuscular Disorders
Volume 19, Issue 6 , Pages 439-443 , June 2009

163rd ENMC International Workshop: Nucleoid and nucleotide biology in syndromes of mitochondrial DNA depletion myopathy 12–14 December 2008, Naarden, The Netherlands

  • Joanna Poulton

      Affiliations

    • The Women’s Centre, John Radcliffe Hospital, Oxford, OX3 9DU, UK
    • Corresponding Author InformationCorresponding author.
    • ,
  • Ian J. Holt

      Affiliations

    • MRC-Dunn Human Nutrition Unit, Wellcome Trust-MRC Building, Hills Road Cambridge, CB2 0XY, UK

Received 6 March 2009

References 

  1. Moraes CT, Shanske S, Tritschler HJ, Aprille JR, Andreetta F, Bonilla E, et al. mtDNA depletion with variable tissue expression: a novel genetic abnormality in mitochondrial diseases. Am J Hum Genet. 1991;48:492–501
  2. Moraes C, Ricci E, Arnaudo E, Bonilla E, DiMauro S, Schon E. Quantitative defects of mitochondrial DNA. In:  DiMauro S,  Wallace D editor. Mitochondrial DNA in human pathology. New York: Raven; 1993;p. 97–108
  3. Ashley N, Adams S, Slama A, Zeviani M, Suomalainen A, Andreu A, et al. Defects in maintenance of mitochondrial DNA are associated with intramitochondrial nucleotide imbalances. Hum Mol Genet. 2007;16:1400–1411
  4. Rötig A, Poulton J. Genetic causes of mitochondrial DNA depletion in humans Biochim Biophys Acta Mol Basis Dis (ELS), in press.
  5. Alberio S, Mineri R, Tiranti V, Zeviani M. Depletion of mtDNA: syndromes and genes. Mitochondrion. 2007;7(1–2):6–12
  6. Sarzi E, Bourdon A, Chretien D, Zarhrate M, Corcos J, Slama A, et al. Mitochondrial DNA depletion is a prevalent cause of multiple respiratory chain deficiency in childhood. J Pediatr. 2007;150(5):531–5344 e1–6
  7. Rahman S, Poulton J. Diagnosis of mitochondrial DNA depletion syndromes. Arch Dis Child. 2009;94(1):3–5
  8. Chinnery PF, Zeviani M. 155th ENMC workshop: Polymerase gamma and disorders of mitochondrial DNA synthesis, 21–23 September 2007, Naarden, The Netherlands. Neuromuscul Disord 2007.
  9. Barthelemy C, de Baulny HO, Lombes A. D-loop mutations in mitochondrial DNA: link with mitochondrial DNA depletion?. Hum Genet. 2002;110(5):479–487
  10. Naviaux RK. Alpers syndrome. Orphanet: the portal for rare diseases and orphan drugs 2006. Available from: http://www.orpha.net/consor/cgi-bin/Disease_Search.php?lng=EN&data_id=1730&Disease_Disease_Search_diseaseGroup=alpers&Disease_Disease_Search_diseaseType=Pat&Disease(s)%20concerned=Alpers-syndrome&title=Alpers-syndrome&search=Disease_Search_Simple.
  11. Poulton J, Sewry C, Potter C, Bourgeron T, Chretien D, Wijburg F, et al. Variation in mitochondrial DNA levels in muscle from normal controls. Is depletion of mitochondrial DNA in patients with mitochondrial myopathy a distinct clinical syndrome?. J Inherit Metab Dis. 1995;18:4–20
  12. Yasukawa T, Reyes A, Cluett TJ, Yang MY, Bowmaker M, Jacobs HT, et al. Replication of vertebrate mitochondrial DNA entails transient ribonucleotide incorporation throughout the lagging strand. EMBO J. 2006;25(22):5358–5371
  13. Chen J, Kadlubar FF, Chen JZ. DNA supercoiling suppresses real-time PCR: a new approach to the quantification of mitochondrial DNA damage and repair. Nucleic Acids Res. 2007;35(4):1377–1388
  14. Human DNA polymerase gamma mutation database [database on the Internet]. NIEHS 2009. Available from: http://tools.niehs.nih.gov/polg/.
  15. Ferraro P, Pontarin G, Crocco L, Fabris S, Reichard P, Bianchi V. Mitochondrial deoxynucleotide pools in quiescent fibroblasts: a possible model for mitochondrial neurogastrointestinal encephalomyopathy (MNGIE). J Biol Chem. 2005;280(26):24472–24480
  16. Pontarin G, Fijolek A, Pizzo P, Ferraro P, Rampazzo C, Pozzan T, et al. Ribonucleotide reduction is a cytosolic process in mammalian cells independently of DNA damage. Proc Natl Acad Sci USA. 2008;105(46):17801–17806
  17. Nishigaki Y, Marti R, Copeland WC, Hirano M. Site-specific somatic mitochondrial DNA point mutations in patients with thymidine phosphorylase deficiency. J Clin Invest. 2003;111(12):1913–1921
  18. Lopez LC, Akman HO, Garcia-Cazorla A, Dorado B, Marti R, Nishino I, et al. Unbalanced deoxynucleotide pools cause mitochondrial DNA instability in thymidine phosphorylase deficient mice. Hum Mol Genet. 2008;
  19. Spinazzola A, Marti R, Nishino I, Andreu AL, Naini A, Tadesse S, et al. Altered thymidine metabolism due to defects of thymidine phosphorylase. J Biol Chem. 2002;277(6):4128–4133
  20. Saada A. Mitochondrial deoxyribonucleotide pools in deoxyguanosine kinase deficiency. Mol Genet Metab. 2008;95(3):169–173
  21. Jeppesen TD, Schwartz M, Frederiksen AL, Wibrand F, Olsen DB, Vissing J. Muscle phenotype and mutation load in 51 persons with the 3243A>G mitochondrial DNA mutation. Arch Neurol. 2006;63(12):1701–1706
  22. Zhou X, Solaroli N, Bjerke M, Stewart JB, Rozell B, Johansson M, et al. Progressive loss of mitochondrial DNA in thymidine kinase 2-deficient mice. Hum Mol Genet. 2008;17(15):2329–2335
  23. Lara MC, Weiss B, Illa I, Madoz P, Massuet L, Andreu AL, et al. Infusion of platelets transiently reduces nucleoside overload in MNGIE. Neurology. 2006;67(8):1461–1463
  24. Moran NF, Bain MD, Muqit MM, Bax BE. Carrier erythrocyte entrapped thymidine phosphorylase therapy for MNGIE. Neurology. 2008;71(9):686–688
  25. Longley MJ, Clark S, Yu Wai Man C, Hudson G, Durham SE, Taylor RW, et al. Mutant POLG2 disrupts DNA polymerase gamma subunits and causes progressive external ophthalmoplegia. Am J Hum Genet. 2006;78(6):1026–1034
  26. Wanrooij S, Goffart S, Pohjoismaki JL, Yasukawa T, Spelbrink JN. Expression of catalytic mutants of the mtDNA helicase Twinkle and polymerase POLG causes distinct replication stalling phenotypes. Nucleic Acids Res. 2007;35(10):3238–3251
  27. Viscomi C, Spinazzola A, Maggioni M, Fernandez-Vizarra E, Massa V, Pagano C, et al. Early-onset liver mtDNA depletion and late-onset proteinuric nephropathy in Mpv17 knockout mice. Hum Mol Genet. 2009;18(1):12–26
  28. Hakonen AH, Isohanni P, Paetau A, Herva R, Suomalainen A, Lonnqvist T. Recessive Twinkle mutations in early onset encephalopathy with mtDNA depletion. Brain. 2007;130(Pt. 11):3032–3040
  29. Taanman JW, Rahman S, Pagnamenta AT, Morris AA, Bitner-Glindzicz M, Wolf NI, et al. Analysis of mutant DNA polymerase gamma in patients with mitochondrial DNA depletion. Hum Mutat. 2008;
  30. Ashley N, O’Rourke A, Smith C, Adams S, Gowda V, Zeviani M, et al. Depletion of mitochondrial DNA in fibroblast cultures from patients with POLG1 mutations is a consequence of catalytic mutations. Hum Mol Genet. 2008;17:2496–2506
  31. Dimmock DP, Dunn JK, Feigenbaum A, Rupar A, Horvath R, Freisinger P, et al. Abnormal neurological features predict poor survival and should preclude liver transplantation in patients with deoxyguanosine kinase deficiency. Liver Transpl. 2008;14(10):1480–1485
  32. Lara MC, Valentino ML, Torres-Torronteras J, Hirano M, Marti R. Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): biochemical features and therapeutic approaches. Biosci Rep. 2007;27(1–3):151–163
  33. Wenz T, Diaz F, Spiegelman BM, Moraes CT. Activation of the PPAR/PGC-1alpha pathway prevents a bioenergetic deficit and effectively improves a mitochondrial myopathy phenotype. Cell Metab. 2008;8(3):249–256
  34. Iacovino M, Granycome C, Sembongi H, Bokori-Brown M, Butow RA, Holt IJ, et al. The conserved translocase Tim17 prevents mitochondrial DNA loss. Hum Mol Genet. 2009;18(1):65–74
  35. Moreno-Loshuertos R, Acin-Perez R, Fernandez-Silva P, Movilla N, Perez-Martos A, de Cordoba SR, et al. Differences in reactive oxygen species production explain the phenotypes associated with common mouse mitochondrial DNA variants. Nat Genet. 2006;38(11):1261–1268
  36. Poulton J et al. Collated mutations in mitochondrial DNA depletion syndrome (excluding POLG1). Biochim Biophys Acta 2009.
  37. Van Goethem G, Dermaut B, Lofgren A, Martin JJ, Van Broeckhoven C. Mutation of POLG is associated with progressive external ophthalmoplegia characterized by mtDNA deletions. Nat Genet. 2001;28(3):211–212
  38. Spelbrink J, Li F, Tiranti V, Nikali K, Yuan Q, Tariq M, et al. Human mitochondrial DNA deletions associated with mutations in the gene for Twinkle, a Phage T7 Gene 4-Like protein localized to mitochondrial nucleoids. Nat Genet. 2001;28:223–231
  39. Kaukonen J, Juselius J, Tiranti V, Kyttala A, Zeviani M, Comi G, et al. Role of adenine nucleotide translocator 1 in mtDNA maintenance. Science 2000;289:782–5.
  40. Nishino I, Spinazzola A, Hirano M. Thymidine phosphorylase gene mutations in MNGIE, a human mitochondrial disorder. Science 1999;283:689–92.
  41. Mandel H, Szargel R, Labay V, Elpeleg O, Saada A, Shalata A, et al. The deoxyguanosine kinase gene is mutated in individuals with depleted hepatocerebral mitochondrial DNA. Nat Genet. 2001;29(3):337–341
  42. Saada A, Shaag A, Mandel H, Nevo Y, Eriksson S, Elpeleg O. Mutant mitochondrial thymidine kinase in mitochondrial DNA depletion myopathy. Nat Genet. 2001;29(3):342–344
  43. Elpeleg O, Miller C, Hershkovitz E, Bitner-Glindzicz M, Bondi-Rubinstein G, Rahman S, et al. Deficiency of the ADP-forming succinyl-CoA synthase activity is associated with encephalomyopathy and mitochondrial DNA depletion. Am J Hum Genet. 2005;76(6):1081–1086
  44. Ostergaard E, Christensen E, Kristensen E, Mogensen B, Duno M, Shoubridge EA, et al. Deficiency of the alpha subunit of succinate-coenzyme A ligase causes fatal infantile lactic acidosis with mitochondrial DNA depletion. Am J Hum Genet. 2007;81(2):383–387
  45. Bourdon A, Minai L, Serre V, Jais JP, Sarzi E, Aubert S, et al. Mutation of RRM2B, encoding p53-controlled ribonucleotide reductase (p53R2), causes severe mitochondrial DNA depletion. Nat Genet. 2007;39(6):776–780
  46. Hudson G, Amati-Bonneau P, Blakely EL, Stewart JD, He L, Schaefer AM, et al. Mutation of OPA1 causes dominant optic atrophy with external ophthalmoplegia, ataxia, deafness and multiple mitochondrial DNA deletions: a novel disorder of mtDNA maintenance. Brain 2007.
  47. Amati-Bonneau P, Valentino ML, Reynier P, Gallardo ME, Bornstein B, Boissiere A, et al. OPA1 mutations induce mitochondrial DNA instability and optic atrophy ‘plus’ phenotypes. Brain. 2008;131(Pt. 2):338–351
  48. Spinazzola A, Viscomi C, Fernandez-Vizarra E, Carrara F, D’Adamo P, Calvo S, et al. MPV17 encodes an inner mitochondrial membrane protein and is mutated in infantile hepatic mitochondrial DNA depletion. Nat Genet. 2006;38:570–575

PII: S0960-8966(09)00114-X

doi: 10.1016/j.nmd.2009.04.009

Neuromuscular Disorders
Volume 19, Issue 6 , Pages 439-443 , June 2009

Article Tools